These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25436319)

  • 41. Safety and optimal management of hepatic arterial infusion chemotherapy after pancreatectomy for pancreatobiliary cancer.
    Hashimoto A; Nishiofuku H; Tanaka T; Sho M; Anai H; Nakajima Y; Kichikawa K
    AJR Am J Roentgenol; 2012 Apr; 198(4):923-30. PubMed ID: 22451562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hepatic arterial infusion therapy for pancreatic cancer].
    Miura Y; Ueda M; Kunihiro O; Kubota T; Endo I; Sekido H; Togo S; Shimada H
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):195-8. PubMed ID: 14997750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma - A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials.
    Kurreck A; Weckwerth J; Modest DP; Striefler JK; Bahra M; Bischoff S; Pelzer U; Oettle H; Kruger S; Riess H; Sinn M
    Eur J Cancer; 2021 Jun; 150():250-259. PubMed ID: 33940349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multidisciplinary approach and multimodal therapy in resected pancreatic cancer. Observational study.
    Morales R; Cuadrado A; Noguera JF; Dolz C; Vilella A; Riera J; González de Cabo M; Arriví A; Falcó E; García Bonafe M; Company M; Vicens JC; Socías A
    Rev Esp Enferm Dig; 2011 Jan; 103(1):5-12. PubMed ID: 21341931
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.
    Wang-Gillam A; Li CP; Bodoky G; Dean A; Shan YS; Jameson G; Macarulla T; Lee KH; Cunningham D; Blanc JF; Hubner RA; Chiu CF; Schwartsmann G; Siveke JT; Braiteh F; Moyo V; Belanger B; Dhindsa N; Bayever E; Von Hoff DD; Chen LT;
    Lancet; 2016 Feb; 387(10018):545-557. PubMed ID: 26615328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5-fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer.
    Takamori H; Kanemitsu K; Tsuji T; Tanaka H; Chikamoto A; Nakahara O; Hiraoka T; Ikeda O; Kudo K; Imuta M; Yamashita Y
    Pancreas; 2005 Apr; 30(3):223-6. PubMed ID: 15782098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen).
    Lorenz M; Müller HH; Schramm H; Gassel HJ; Rau HG; Ridwelski K; Hauss J; Stieger R; Jauch KW; Bechstein WO; Encke A
    Ann Surg; 1998 Dec; 228(6):756-62. PubMed ID: 9860474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the efficacy of combined continuous arterial infusion and systemic chemotherapy for the treatment of advanced pancreatic carcinoma.
    Ikeda O; Kusunoki S; Kudoh K; Takamori H; Tsuji T; Kanemitsu K; Yamashita Y
    Cardiovasc Intervent Radiol; 2006; 29(3):362-70. PubMed ID: 16502181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
    Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
    Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. One year survival with poorly differentiated metastatic pancreatic carcinoma following chemoembolization with gemcitabine and cisplatin.
    Brown DB; Gonsalves CF; Yeo CJ; Witkiewicz AK; Carr BI
    Oncol Rep; 2010 Sep; 24(3):767-9. PubMed ID: 20664985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver perfusion chemotherapy with 5-Fluorouracil followed by systemic gemcitabine administration for resected pancreatic cancer: preliminary results of a prospective phase 2 study.
    Kurosaki I; Kawachi Y; Nihei K; Tsuchiya Y; Aono T; Yokoyama N; Shimizu T; Hatakeyama K
    Pancreas; 2009 Mar; 38(2):161-7. PubMed ID: 18797423
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A case of liver metastasis of pancreatic cancer that was resistant to S-1 and gemcitabine successfully treated by 5-FU and cisplatin hepatic arterial infusion].
    Iwauchi T; Amano R; Ohira G; Nakamoto K; Doi Y; Yamada N; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2373-5. PubMed ID: 21224577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Adjuvant arterial infusion chemotherapy for patients with pancreatic cancer].
    Takeda Y; Hasuike Y; Kashiwazaki M; Tsujinaka T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1762-5. PubMed ID: 14619513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.
    Kudo M; Ueshima K; Yokosuka O; Ogasawara S; Obi S; Izumi N; Aikata H; Nagano H; Hatano E; Sasaki Y; Hino K; Kumada T; Yamamoto K; Imai Y; Iwadou S; Ogawa C; Okusaka T; Kanai F; Akazawa K; Yoshimura KI; Johnson P; Arai Y;
    Lancet Gastroenterol Hepatol; 2018 Jun; 3(6):424-432. PubMed ID: 29631810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study.
    Wang Y; Sun XR; Feng WM; Bao Y; Zheng YY
    Onco Targets Ther; 2016; 9():5897-5902. PubMed ID: 27713643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases.
    Kemeny N; Conti JA; Sigurdson E; Cohen A; Seiter K; Lincer R; Niedzwiecki D; Botet J; Chapman D; Costa P
    Cancer; 1993 Mar; 71(6):1964-71. PubMed ID: 8443746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
    Uesaka K; Boku N; Fukutomi A; Okamura Y; Konishi M; Matsumoto I; Kaneoka Y; Shimizu Y; Nakamori S; Sakamoto H; Morinaga S; Kainuma O; Imai K; Sata N; Hishinuma S; Ojima H; Yamaguchi R; Hirano S; Sudo T; Ohashi Y;
    Lancet; 2016 Jul; 388(10041):248-57. PubMed ID: 27265347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of hepatic arterial infusion chemotherapy for gastric cancer].
    Uemura T; Kawasaki S; Kawai H; Suga M; Maruyama S; Otani J; Morisue S; Yoshizane K; Morokoshi Y; Yamamoto M; Soda M
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1787-91. PubMed ID: 8937489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic arterial infusion chemotherapy prior to standard systemic chemotherapy in patients with highly advanced unresectable liver metastases from colorectal cancer: a report of three patients.
    Iguchi T; Idani H; Asami S; Endo H; Inaba Y; Arai Y; Kanazawa S
    Acta Med Okayama; 2011 Feb; 65(1):49-53. PubMed ID: 21339796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic Arterial Infusion Chemotherapy of 5-Fluorouracil for Patients with Unresectable Liver Metastases from Colorectal Cancer Refractory to Standard Systemic Chemotherapy: A Multicenter Retrospective Study.
    Sato Y; Inaba Y; Aramaki T; Sone M; Morita Y; Nishiofuku H; Tanaka T; Miyazaki M; Matsueda K; Arai Y
    Oncology; 2020; 98(5):267-272. PubMed ID: 32092755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.